-
Use of Statistics to Assess Serious Adverse Events in Clinical Trials of New Drugs: Cross-Sectional Study of FDA Review Memos | Journal of General Internal Medicine | Sarah Tanveer et al. (link.springer.com)Less than half of serious adverse events analyses submitted to the FDA in 2022 as part of a successful new drug application followed the statistical preferences encouraged by the FDA. Seems like the sort of problem that should not exist anymore with AI.
-
Interesting new tool to help innovation policymakers with a gorgeous UX
-
How Artificial Intelligence Shapes Science: Evidence from AlphaFold — Ryan Hill & Carolyn Stein (carolynstein.github.io)Interesting early evidence of complementarity, “floodlighting” & perhaps a biology-AI Amdhal’s law
-
An early vision describing humanity’s role in science as largely hermeneutical
-
Ex Post Ben & Ex Ante Ben Walk Into a Blog Post
-
Ruxandra describes a case study in a new treatment for childhood leukemia showing how clinical trials should be thought of as part of the discovery process and not just a final seal
-
Interesting approach to increase the scope of evidence based arguments in medicine
-
Interesting analysis from @Mattsclancy
-
Fun article with examples on Bayesian epistemology featuring athlete's foot, toenails and vitamin C
Repost this lynk